Related references
Note: Only part of the references are listed.Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
Junmin Zhang et al.
MEDICINAL RESEARCH REVIEWS (2019)
STAT3 differential scanning fluorimetry and differential scanning light scattering assays: Addressing a missing link in the characterization of STAT3 inhibitor interactions
Matthieu Desroses et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
William C. Stafford et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Brent D. G. Page et al.
NATURE COMMUNICATIONS (2018)
Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
Mihwa Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Novel thioredoxin reductase inhibitor butaselen inhibits tumorigenesis by down-regulating programmed death-ligand 1 expression
Qiao Zou et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2018)
The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells
Katja Linher-Melville et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Time- and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells
Anna P. Kipp et al.
REDOX BIOLOGY (2017)
Identification of novel small molecules that inhibit STAT3-dependent transcription and function
Iryna Kolosenko et al.
PLOS ONE (2017)
Strategies and Approaches of Targeting STAT3 for Cancer Treatment
Stefanie L. Furtek et al.
ACS CHEMICAL BIOLOGY (2016)
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities
Ahmed M. Ali et al.
CHEMMEDCHEM (2016)
Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors
Steffanie L. Furtek et al.
ONCOTARGET (2016)
Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent
Daniel P. Ball et al.
ONCOTARGET (2016)
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
Isaac S. Harris et al.
CANCER CELL (2015)
A STAT inhibitor patent review: progress since 2011
Ping-Shan Lai et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
CETSA: a target engagement assay with potential to transform drug discovery
Annika Jenmalm Jensen et al.
FUTURE MEDICINAL CHEMISTRY (2015)
High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis
Ting Li et al.
INFECTIOUS DISEASES OF POVERTY (2015)
Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling
Mirko C. Sobotta et al.
NATURE CHEMICAL BIOLOGY (2015)
Regulation of Protein Tyrosine Phosphatase Oxidation in Cell Adhesion and Migration
Jeroen Frijhoff et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
Ho-June Lee et al.
CANCER CELL (2014)
STAT3 and metabolism: How many ways to use a single molecule?
Marco Demaria et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Investigation of the protein alkylation sites of the STAT3:STAT3 inhibitor Stattic by mass spectrometry
Sibylle Heidelberger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
Alfonso Quintas-Cardama et al.
CLINICAL CANCER RESEARCH (2013)
Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase
Xiaoxiao Peng et al.
BIOCHEMICAL JOURNAL (2012)
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
Xiaolei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
Brent D. G. Page et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Susceptibility of the Antioxidant Selenoenyzmes Thioredoxin Reductase and Glutathione Peroxidase to Alkylation-Mediated Inhibition by Anticancer Acylfulvenes
Xiaodan Liu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Loss of Thioredoxin Reductase 1 Renders Tumors Highly Susceptible to Pharmacologic Glutathione Deprivation
Pankaj Kumar Mandal et al.
CANCER RESEARCH (2010)
System xc- and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione Deficiency
Pankaj Kumar Mandal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery
Xue-Ming Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Focus on mammalian thioredoxin reductases - Important selenoproteins with versatile functions
Elias S. J. Arner
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells
Karin Anestal et al.
PLOS ONE (2008)
Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3
Nam-Hoon Kim et al.
IMMUNOLOGY (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds
AB Witte et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Share Paper
